[
  {
    "dataset_info": {
      "dataset_accession": "",
      "datasets": ["LDG-1241", "LDG-1242", "LDG-1243", "LDG-1244", "LDG-1245", "LDG-1246", "LDG-1247"]
    },
    "title": "Dose-Response Analysis",
    "subtitle": "LINCS Center for Transcriptomics - HMS LINCS Center Joint Project",
    "lca_accession": "",
    "dataset_url": "",
    "tool_name": "GR Browser",
    "tool_logo_url": "http://lincsproject.org/LINCS/files/tools_logos/GR_Calculator_logo.png",
    "analysis_center": "HMS-LINCS",
    "analysis_center_logo": "http://lincsproject.org/LINCS/files/centers_logos/hms-lincs.png",
    "analysis_center_url": "/LINCS/centers/data-and-signature-generating-centers/hms-lincs",
    "tool_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_description": "The dose-dependent sensitivities of 6 nonmalignant breast and breast cancer cell lines were assayed by the HMS LINCS Center by measuring cell counts 72 hours after treatment with each of 107 small molecule perturbagens across a 6-point dose range.",
    "screen_path": "./ca_screenshot/multi_03_gr_browser.png"
  },
  {
    "dataset_info": {
      "dataset_accession": "",
      "datasets": ["HMS-20278", "HMS-20279", "HMS-20280", "HMS-20281", "HMS-20282", "HMS-20283", "HMS-20284", "HMS-20285", "HMS-20286"]
    },
    "title": "Dose-Response Analysis",
    "subtitle": "LINCS MCF 10A Common Project",
    "lca_accession": "",
    "dataset_url": "",
    "tool_name": "GR Browser",
    "tool_logo_url": "http://lincsproject.org/LINCS/files/tools_logos/GR_Calculator_logo.png",
    "analysis_center": "HMS-LINCS",
    "analysis_center_logo": "http://lincsproject.org/LINCS/files/centers_logos/hms-lincs.png",
    "analysis_center_url": "/LINCS/centers/data-and-signature-generating-centers/hms-lincs",
    "tool_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_description": "The dose-dependent sensitivities of three independent batches and one derivative of the nonmalignant breast cell line MCF 10A were assayed independently by five of the LINCS DSGCs by measuring cell counts using imaging or by estimating cell proliferation using the CellTiter-Glo® assay 72 hours after treatment with each of 8 small molecule perturbagens across a 9-point dose range.",
    "screen_path": "./ca_screenshot/multi_03_gr_browser.png"
  },
  {
    "dataset_info": {
      "dataset_accession": "",
      "datasets": ["LDG-1252" ,"LDG-1253" ,"LDG-1254"]
    },
    "title": "Dose-Response Analysis",
    "subtitle": "HMS LINCS Center Seeding Density Project",
    "lca_accession": "",
    "dataset_url": "",
    "tool_name": "GR Browser",
    "tool_logo_url": "http://lincsproject.org/LINCS/files/tools_logos/GR_Calculator_logo.png",
    "analysis_center": "HMS-LINCS",
    "analysis_center_logo": "http://lincsproject.org/LINCS/files/centers_logos/hms-lincs.png",
    "analysis_center_url": "/LINCS/centers/data-and-signature-generating-centers/hms-lincs",
    "tool_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_description": "The density- and context-dependent sensitivities of 6 breast cancer cell lines plated at 6 different cell densities were assayed by the HMS LINCS Center by measuring cell counts using imaging 72 hours after treatment with each of 12 small molecule inhibitors across a 9-point dose range.",
    "screen_path": "./ca_screenshot/multi_03_gr_browser.png"
  },
  {
    "dataset_info": {
      "dataset_accession": "",
      "datasets": ["HMS-20268", "HMS-20269", "HMS-20270", "HMS-20271"]
    },
    "title": "Dose-Response Analysis",
    "subtitle": "MEP LINCS Center - HMS LINCS Center Joint Project",
    "lca_accession": "",
    "dataset_url": "",
    "tool_name": "GR Browser",
    "tool_logo_url": "http://lincsproject.org/LINCS/files/tools_logos/GR_Calculator_logo.png",
    "analysis_center": "HMS-LINCS",
    "analysis_center_logo": "http://lincsproject.org/LINCS/files/centers_logos/hms-lincs.png",
    "analysis_center_url": "/LINCS/centers/data-and-signature-generating-centers/hms-lincs",
    "tool_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_url": "http://www.grcalculator.org/grbrowser/",
    "canned_analysis_description": "The dose-dependent sensitivities of 73 nonmalignant breast and breast cancer cell lines were assayed by the MEP LINCS Center by estimating proliferation using the CellTiter-Glo® assay 72 hours after treatment with each of 139 small molecule and antibody perturbagens across a 9-point dose range. Analysis of a subset of these data using traditional growth inhibition metrics (GI50) was previously described in Heiser et al. (2012) (PMID: 22003129) and Daemen et al. (2013) (PMID: 24176112). Here, the complete dataset was reanalyzed by the HMS LINCS Center using GR metrics to account for differences in growth rates across the cell lines and treatment conditions.",
    "screen_path": "./ca_screenshot/multi_03_gr_browser.png"
  }
]
